Fabry disease
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. The healthy volunteer is willing and able to provide signed informed consent prior to study-related procedures. 2. The healthy volunteer is >=18 years of age.
Exclusion criteria
Exclusion criteria: 1. Use of anticoagulants (e.g. vitamin K antagonist)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Part one: amount of mRNA of GB3 synthase as measured by RT-PCR on fibroblast and white blood cells and GB3 amount as measured by HPLC. Part two: correlation between plasma lyso (GB3) and P blood group status, Fabry disease severity as measured by FOS-SSI and age at onset of first clinical event by Kaplan Meier analysis. | — |
Countries
Netherlands
Outcome results
None listed